Table 3. Primary pharmacokinetic parameters of paclitaxel in rats after intravenous administration of Taxol, Abraxane, or self-made nanoparticles at a paclitaxel dose of 7mg/kg (n = 5).
Parameters | Taxol | Abraxane | Self-made nanoparticles |
---|---|---|---|
Cmax(ng/mL) | 2069.3±518.4b | 4713.3±743.0a | 4437.8±822.2a |
T1/2(h) | 1.97±0.08b | 2.47±0.13a | 2.49±0.16 a |
AUC0-inf(μg·h/mL) | 2.87±1.01b | 7.51±1.46 a | 8.23±1.06a |
CL(L/h) | 0.67±0.26 | 0.24±0.05 | 0.22±0.03 |
Vss(L) | 1.57±0.76 | 0.66±0.13 | 0.57±0.08 |
MRT(h) | 2.30±0.26 | 2.75±0.05 | 2.66±0.12 |
a p<0.05 compared with Taxol;
b p<0.05 compared with Abraxane.